European Leukemia Trial Registry
Trial: TEMDS

More Details
Title Temsirolimus in Myelodysplastic Syndrome
Scientific Title Treatment of MDS patients with single agent temsirolimus - a pilot study
Short Title TEMDS
Trialgroup Deutsche MDS
Type of Trial multicentric, open-label, pilot study
Disease Myelodysplastic Syndrome(MDS) Low risk and intermedia I
Myelodysplastic Syndrome(MDS) Intermedia II and high risk
Age >= 18 years
Status Closed
Start of Recruitment 15.12.2009
Leader Platzbecker, Prof. Dr. med., Uwe
Contactperson

principal investigator
Platzbecker, Prof. Dr. med., Uwe
Tel: +49 (0)351 4582583
Fax: +49 (0)351 458-5362
Email: Uwe.Platzbecker@uniklinikum-dresden.de

Study Physician
Wermke, Dr. med., Martin
Tel: +49 (0)351 458 15624
Email: Martin.Wermke@uniklinikum-dresden.de

Centre of Trial Universitätsklinikum Carl Gustav Carus, Dresden
Shortprotocol Shortprotocol
Diagnostics

Zytomorphology
Hämatologisches Labor, Universitätsklinikum Dresden

Cytogenetics
Labor für hämatologische Zytogenetik Göttingen

created 05.01.2010 Irene Gleske
changed 13.11.2014 Alexandra Lucaciu
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org